PRL and bipolar disorder: A 2-year double-blind placebo-controlled study found that, for youth with bipolar depression, lurasidone was generally well tolerated, safe, and effective with relatively low rates of discontinuation due to adverse events, and had minimal effects on weight, metabolic parameters, or prolactin [47].